期刊文献+

灼口综合征患者血清细胞因子水平变化及疗效观察

Changes and curative effect of serum cell cytokine of burning mouth syndrome(BMS) patients before and after medical treatment
原文传递
导出
摘要 目的 探讨灼口综合征患者治疗前后血清IL-2、6和TNF-α水平的变化及疗效.方法 选择灼口综合征患者50例(病例组)予以氯硝西泮片2 mg,1次/d;氟西汀胶囊20 mg,1次/d,连用4周.观察并比较治疗前和治疗4周后血浆细胞因子IL-2、6和TNF-α水平的变化,并进行临床疗效观察.另选择同期在体检中心体检的健康者30例作为对照组.结果 治疗前病例组血清IL-2、6和TNF-α水平明显高于对照组(=4.31、2.97、3.84,均P<0.01).治疗4周后,患者血清IL-2、6和TNF-α水平均较治疗前明显下降(t=2.88、2.34、3.21,P<0.05或P<0.01).治疗4周后病例组治愈6例、显效14例和有效24例,临床总有效率高达88.0% (44/50).结论 灼口综合征患者存在血清IL-2、6和TNF-α水平的异常升高,可作为灼口综合征早期诊断的敏感血清学指标.血清IL-2、6和TNF-α水平的变化可作为灼口综合征患者治疗疗效随访和预后观察的指标. Objective To discuss changes and curative effect of serum interleukin-2 and 6 and tumor necrosis factor-α (TNF-α) of burning mouth syndrome (BMS) patients before and after medical treatment.Methods 50 cases of BMS patients were selected as case group,and who were given Clonazepam tablets (2mg) and Fluoxetine capsules (20 mg) one time daily for 4 weeks.Observe and compare the changes of serum IL-2 and 6,and TNF-αof patients in two groups before and after 4 weeks' medical treatment,and proceeded with the clinical curative effect observation.Moreover,30 cases of healthy subjects who just took the physical examination in medical examination center(MEC) at that moment was the control group.Results The serum IL-2 and IL-6,and TNF-αlevels of patients in case group before medical treatment was obviously higher than those in control group (t =4.31,2.97,3.84,all P 〈0.01).After 4 weeks' medical treatment,serum IL-2 and IL-6,and TNF-αlevels of patients had obviously declined than before (t =2.88,2.34,3.21,P 〈 0.05 or P 〈 0.01).After 4 weeks' medical treatment,there were 6 cured cases,14 cases with significant effect,and 24 cases with curative effect,and the total clinical efficiency reaches 88.0% (44/50).Conclusion BMS patients have abnormal elevation of serum IL-2 and 6,and TNF-α,which may be the sensitive serological indicators of the early diagnosis of BMS.The changes of serum IL-2 and IL-6,and TNF-α levels may be the index of follow-up curative effect and prognosis observation.
作者 万玉芬
出处 《中国基层医药》 CAS 2014年第8期1145-1147,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 灼口综合征 白细胞介素 肿瘤坏死因子 BURNING MOUTH Syndrome(BMS) Interleukin Tumor Necrosis Factor
  • 相关文献

参考文献13

  • 1Lauria G,Majorana A,Borgan M,et al.Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome[J].Pain,2005,115(3):332-337. 被引量:1
  • 2顾远平,何克新.灼口综合征的研究状况[J].齐齐哈尔医学院学报,2011,32(15):2490-2492. 被引量:6
  • 3陈谦明.口腔黏膜病学[M].北京:人民卫生出版社,2008:160-162. 被引量:47
  • 4李幼华,胡珍玉,杨生刚,陈冉冉,吴伟.灼口综合征心理药物综合治疗的临床观察[J].口腔医学,2008,28(1):31-34. 被引量:10
  • 5Maina M,Albert U,Grandolfo S,et al.Personality disorders in patients with burning mouth syndrome[J].Personal Disorder,2005,19(1):84-93. 被引量:1
  • 6刘蓓丽,叶周熹(综述),唐国瑶(审校).原发型灼口综合征疼痛发生的神经机制研究进展[J].临床口腔医学杂志,2012,28(8):508-510. 被引量:7
  • 7Minguez-Sanz MP,Salort-Llorca C,Silvestre-Donat FJ.Etiology of burning mouth syndrome:a review and update[J].Med Oral Patol Oral Cir Bucal,2011,16(2):144-148. 被引量:1
  • 8Beneng K,Yilmaz Z,Yiangou Y,et al.Sensory purinergic receptor P2X3 is elevated in burning mouth syndrome[J].Int J Oral Maxillo-fac Surg,2010,39(8):815-819. 被引量:1
  • 9Stuginski-Barbosa J,Rodrigues GG,Bigal ME,et al.Burning mouth syndrome responsive to pramipexol[J].Headache Pain,2008,9(1):43-45. 被引量:1
  • 10Albuquerque R J,de Leeuw R,Carlson CR,et al.Cerebral activation during thermal stimulation of patients who have burning mouth disorder:an fMRI study[J].Pain,2006,122 (3):223-234. 被引量:1

二级参考文献62

  • 1Grushka M,Epstein JB,Gorsky IM.Burning mouth syndrome[J].Am Fam Physician,2002,65(4):615-620. 被引量:1
  • 2Carlson CR,Miller CS,Reid KI.Psychosocial profiles of patients with burning mouth syndrome[J].J Orofac Pain,2000,14(1):59-64. 被引量:1
  • 3Hagelberg N,Forssell H,Rinne JO,et al.Striatal dopamine D1 and D2 receptors in burning mouth syndrome[J].Pain,2003,101(1-2):149-154. 被引量:1
  • 4Hagelberg N,Forssell H,Aalto S,et al.Altered dopamine D2 receptor binding in atypical facial pain[J].Pain,2003,106(1-2):43-48. 被引量:1
  • 5Forssell H,Jaaskelainen SK,Tenovuo O,et al.Sensory dysfunction in burning mouth syndrome[J].Pain,2002,99(1-2):41-47. 被引量:1
  • 6Dias Fernandes CS, Salum FG, Bandeira D,et al. Salivary de- hydroepiandrosterone (DHEA) levels in patients with the complaint of burning mouth: a case--control study[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009,108 (4) : 537--543. 被引量:1
  • 7Borelli V, Marchioli A, Di Taranto R,et al. Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study [J]. OralDis,2010,16(4):365--374. 被引量:1
  • 8Cavalcanti DR, Birman EG, Migliari DA,et al. Burning mouth syn- drome: clinical profile of Brazilian patients and oral carriage of Candida soecies[J]. Braz Dent J,2007,18(4):341--345. 被引量:1
  • 9El--Etr M. Critical commentary 3: steroid dysregulation and stomatodynia (burning mouth syndrome)[J]. J Orofac Pain, 2009,23(3) :216-218. 被引量:1
  • 10Hugoson A,Thorstensson B. Vitamin B status and response to replacement therapy in patients with burning mouth syndrome [J]. Acta Odontol Scand, 1949(6):367--375. 被引量:1

共引文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部